Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
Special report on the deposit and use of raised funds in 2021
Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) (hereinafter referred to as ” Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) ,” the company “or” the company “) the board of directors in accordance with the guidelines for the application of self regulatory rules for companies listed on the science and Innovation Board of Shanghai Stock Exchange No. 1 – regulation
According to the requirements of standard operation and relevant format guidelines, the “about 2021” as of December 31, 2021 has been prepared
Special report on the annual deposit and use of raised funds. The details are as follows:
1、 Basic information of raised funds
（1） Actual amount of raised funds and arrival time of funds
The company was approved to register in the reply on approval of Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) initial public offering registration (zjxk [2020] No. 1584) issued by the China Securities Regulatory Commission, and issued 30.09 million RMB ordinary shares (A shares) to the public at the issue price of RMB 44.36 per share. The total amount of funds raised was RMB 133479240000, after deducting the issuance expenses (excluding tax) of RMB 11208398349, The net amount of funds raised this time is 122270841651 yuan. The availability of the above raised funds has been verified by Zhonghui Certified Public Accountants (special general partnership), which issued the capital verification report (Zhonghui kuaiyan [2020] No. 5681) 1 on August 26, 2020.
（2） Use and balance of raised amount
As of December 31, 2021, the balance of raised funds (including the net amount of interest income deducting bank charges)
The balance was 2484336 million yuan.
The details are as follows (unit: RMB 10000):
Project amount
Total raised funds 13347924 less: brokerage underwriting Commission and recommendation fee 909118 total received raised funds 12438806 less: amount of self raised funds invested in advance replaced by raised funds 1066929 minus: 726.00 of the amount paid in advance for the issuance expenses replaced by the raised funds minus: 139121 of the amount paid for the issuance expenses excluding tax minus: 5806423 of the amount directly invested in the raised projects
1. The difference between the net raised funds of 122270841651 yuan in this assurance report and 122270065941 yuan in the capital verification report is 775710 yuan, which is the difference between the planned issuance expenses and the actual situation: 1 The actual issuance report production cost is 943393 yuan lower than expected; 2. The actual stamp duty is 167683 yuan higher than expected.
Project amount
Minus: balance of 3140000 yuan for purchasing financial products, time deposits and structured deposits plus: net amount of 270603 yuan deducted from accumulated income and interest income of financial products, time deposits and structured deposits and handling charges, balance of raised funds on December 31, 20212484336 yuan
2、 Management of raised funds
（1） Management of raised funds
According to the law of the people’s Republic of China on the protection and management of the interests of listed companies, and the law of the people’s Republic of China on the supervision and administration of the use of funds raised by listed companies, No. 2, the law on the protection and management of the interests of listed companies, and the law of the people’s Republic of China on the supervision and administration of the use of funds raised by listed companies The company has formulated the measures for the administration of raised funds (hereinafter referred to as the measures) in accordance with the provisions of relevant laws, regulations and normative documents such as the rules for the listing of shares on the science and Innovation Board of Shanghai Stock Exchange (revised in December 2020), the guidelines for the application of self regulatory rules for companies listed on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation, and in combination with the actual situation of the company. According to the management measures, the company has adopted a special account storage system for the funds raised, set up a special account for the funds raised in the bank, and along with the sponsor, the Tsingtao Brewery Company Limited(600600) 60030 chengduqingyang Industrial Park sub branch Bank Of China Limited(601988) Tianfu New Area Huayang sub branch signed the three (four) party supervision agreement for raised funds, which defined the rights and obligations of all parties. There is no significant difference between the three (4) party supervision agreement and the model three (4) party supervision agreement of Shanghai Stock Exchange. The company has strictly followed and performed the raised funds in order to facilitate the management and use of the raised funds and supervise their use, so as to ensure the special use of funds.
（2） Special account storage of raised funds
As of December 31, 2021, the company has 8 special accounts for raised funds and 1 financial management account for raised funds
The storage of raised funds in the special account is as follows (unit: RMB 10000):
Deposit bank account number account category storage balance remarks
China Construction Bank Corporation(601939) raised funds special account current
Chengdu Qingyang Industrial Park sub branch 510501426295 Shenzhen Fountain Corporation(000005) 435437.99
Bank Of Chengdu Co.Ltd(601838) Fangcao sub branch 100130 China High-Speed Railway Technology Co.Ltd(000008) 0290 special account for raised funds 167446 current account
China Citic Bank Corporation Limited(601998) Chengdu Shuhan sub branch 8111001013200676400 special account for raised funds 26.33 current account
Agricultural Bank Of China Limited(601288) current account for raised funds
Chengdu Jinsha Xiyuan sub branch 2289230104 Dongrui Food Group Co.Ltd(001201) 816.41
China Citic Bank Corporation Limited(601998) Chengdu Yingbin Avenue sub branch 8111001013900674850 special account for raised funds – October 2021
Deposit bank account number account category storage balance remarks
Bank Of China Limited(601988) Tianfu New Area Huayang sub branch 117217817048 special account for raised funds 1158859 current account
China Citic Bank Corporation Limited(601998) Chengdu Shuhan sub branch 8111001012400676405 special account for raised funds 116.40 current account
Industrial And Commercial Bank Of China Limited(601398) special account for raised funds current Chengdu Gaoxin Yongfeng Road sub branch 44029220191 Huafon Chemical Co.Ltd(002064) 6761.02
China Citic Bank Corporation Limited(601998) Chengdu special account for raised funds current Zijing sub branch 81110010124007797191279.18
Bank of Dalian Co., Ltd. Chengdu current branch of raised funds 116727 Shenzhen Properties & Resources Development (Group) Ltd(000011) 16 special financial account 464298
Total — 2484336-
3、 Actual use of raised funds this year
（1） Use of funds for investment projects with raised funds
See Appendix 1 of this report for the comparison table of the use of raised funds in 2021.
（2） Advance investment and replacement of investment projects with raised funds
On September 25, 2020, the company held the 13th meeting of the second board of directors and the 9th meeting of the second board of supervisors, deliberated and approved the proposal on using raised funds to replace self raised funds invested in projects invested with raised funds in advance and paid issuance expenses, and agreed to use raised funds to replace 7.26 million yuan of paid issuance expenses and 1066929 million yuan of self raised funds invested in projects invested with raised funds in advance, The total is 1139529 million yuan. The replacement amount has been verified by Zhonghui Certified Public Accountants (special general partnership) and issued the verification report on Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) pre investment of raised capital investment projects and paid issuance expenses with self raised funds (Zhonghui kuaijin [2020] No. 6001) on September 16, 2020. The independent directors and sponsors of the company have expressed clear consent. (Announcement No.: 2020005)
（3） Temporary replenishment of working capital with idle raised funds
As of December 31, 2021, the company has not temporarily supplemented working capital with idle raised funds in this year.
（4） Cash management of idle raised funds and investment in related products
On September 25, 2020, the company held the 13th meeting of the second board of directors and the 9th meeting of the second board of supervisors, deliberated and approved the proposal on using temporarily idle raised funds for cash management, and agreed that the company would use temporarily idle raised funds of no more than 700 million yuan (including this amount) for cash management without affecting the safety of raised funds and the use schedule of investment project funds, For the purchase of investment products with high security and good liquidity (including but not limited to structured deposits, time deposits, certificates of deposit, etc.), within the above limit, the funds can be used on a rolling basis, and the service life shall not exceed 12 months from the date of deliberation and approval by the board of directors. (Announcement No.: 2020002).
On September 25, 2021, the company held the 21st Meeting of the second board of directors and the 14th meeting of the second board of supervisors, deliberated and adopted the proposal on the use of temporarily idle raised funds for cash management, and agreed that the company would use temporarily idle raised funds of no more than 600 million yuan (including this amount) for cash management on the premise of ensuring that the safety of raised funds and the use schedule of invested project funds would not be affected, The use of the above-mentioned fixed-term deposits and fixed-term deposits is not limited to the safe use of the above-mentioned fixed-term deposits and fixed-term deposits (not limited to 12 months from the date of deliberation by the board of directors), but they can be used for the safe use of the above-mentioned products. (Announcement No.: 2021037)
As of December 31, 2021, the balance of financial products and structured deposits purchased by the company with idle raised funds was 314 million yuan, which did not exceed the authorization scope of the board of directors for cash management of raised funds. The details are as follows:
Trustee’s product name subscription amount maturity income starting date maturity date whether to redeem (10000 yuan)（
